At a glance
- Originator Proteome Systems
- Class Organometallic compounds; Small molecules
- Mechanism of Action Oxygen radical scavengers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cognition disorders
Most Recent Events
- 30 Dec 2008 Discontinued - Preclinical for Cognition disorders in USA (Injection)
- 08 Dec 2006 Preclinical development is still ongoing
- 08 Jul 2003 Preclinical trials in Cognition disorders in USA (Injection)